Sex Hormones and Pulmonary Vascular and Right Ventricular Dysfunction

$275,949P20FY2014GMNIH

Ocean State Research Institute, Inc., Providence RI

Investigators

Linked publications & trials

Paper 39763770 Paper 39605457 Paper 39405112 Paper 39321902 Paper 38659956 Paper 38576776 Paper 38567372 Paper 38293916 Paper 38268025 Paper 38110438 Paper 38055686 Paper 38040328 Paper 38030384 Paper 38001239 Paper 37956482 Paper 37660771 Paper 37561446 Paper 37528869 Paper 37421433 Paper 37289545 Paper 37244562 Paper 37184227 Paper 37104963 Paper 37086653 Paper 36780477 Paper 36748476 Paper 36719084 Paper 36650158 Paper 36639609 Paper 36621212 Paper 36523606 Paper 36496404 Paper 36358506 Paper 36334168 Paper 36241106 Paper 36196201 Paper 36175355 Paper 36130991 Paper 35964084 Paper 35951428 Paper 35943160 Paper 35934505 Paper 35916983 Paper 35679109 Paper 35585756 Paper 35555184 Paper 35444718 Paper 35380932 Paper 35108537 Paper 35018410 Paper 34999843 Paper 34954003 Paper 34907117 Paper 34831028 Paper 34741227 Paper 34720089 Paper 34585590 Paper 34506225 Paper 34432628 Paper 34417157 Paper 34417156 Paper 34400686 Paper 34288720 Paper 34274141 Paper 34117285 Paper 34113789 Paper 34072997 Paper 34064603 Paper 34042288 Paper 33974567 Paper 33882301 Paper 33841163 Paper 33829119 Paper 33769690 Paper 33735685 Paper 33733622 Paper 33681229 Paper 33641552 Paper 33559477 Paper 33497360 Paper 33470641 Paper 33469603 Paper 33430704 Paper 33240486 Paper 33144707 Paper 33137155 Paper 33011119 Paper 32992485 Paper 32918797 Paper 32885987 Paper 32833898 Paper 32825609 Paper 32815166 Paper 32786064 Paper 32702536 Paper 32672471 Paper 32493616 Paper 32359903 Paper 32199682 Paper 32199659

Abstract

PROJECT SUMMARY (See instructions); Female sex is the best established risk factor for pulmonary arterial hypertension (PAH), yet women have preserved right ventricular (RV) function and survival compared to men with PAH. This so-called estrogen paradox is as yet unexplained. RV function determines outcome in disease, but the mechanisms and determinants of RV failure are unknown. We hypothesize that high estrogen states promote pulmonary vascular angiogenesis and RV myocardial collateral flow, resulting in pleiotropic effects on the pulmonary vasculature and the RV. In postmenopausal women, the hormonal mileu (e.g., sex hormone and estradiol [E2] metabolite levels) can be characterized; in premenopausal women the normal menstrual cycle (marked by a predictable spike in E2) provides a physiologic model to characterize these relationships. We propose: 1) a prospective cohort study (N=75) to determine whether the sex hormone milieu is associated with markers of angiogenesis (vascular endothelial growth factor [VEGF], angiopoietins [Ang], endothelial progenitor cells [EPCs]) and RV function assessed by hemodynamics in postmenopausal women wdth PAH and 2) a prospective case-control study (N = 40) to determine whether the menstrual cycle is associated with markers of angiogenesis (VEGF, Ang, EPCs) and RV function assessed by echocardiography in premenopausal women with PAH as compared to controls. We anticipate that in both pre and postmenopausal women, high E2 states will be associated with higher levels of angiogenesis markers but improved surrogates of RV function. The extent to which the influence of sex hormones on markers of angiogenesis and RV function can be defined is supported by 1) the use of separate studies to incorporate both pre and postmenopausal women and 2) the combination of a variety of carefully selected biomarkers aimed at both angiogenesis and RV function.

View original record on NIH RePORTER →